Summary
In an Editorial in July 2023, we wrote with optimism about the antifungal clinical development pipeline. At the time, several new drugs were in late-stage clinical trials and/or had been approved by regulatory bodies,
Source: The Lancet
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
